| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,906 |
12,320 |
$915K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,694 |
10,179 |
$679K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,406 |
8,365 |
$589K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,708 |
1,691 |
$144K |
| 99058 |
|
882 |
820 |
$56K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,159 |
2,031 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,551 |
3,423 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
888 |
880 |
$5K |
| 81025 |
|
1,463 |
1,444 |
$4K |
| 81002 |
|
3,471 |
3,383 |
$4K |
| 87428 |
|
197 |
196 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
134 |
131 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
297 |
285 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,047 |
2,004 |
$811.95 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$738.32 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
20 |
$690.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28 |
28 |
$467.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
251 |
240 |
$165.52 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
13 |
$33.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
51 |
49 |
$15.59 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
144 |
142 |
$0.15 |
| 94760 |
|
702 |
690 |
$0.00 |
| 99070 |
|
66 |
66 |
$0.00 |